Pliant Therapeutics, Inc.
PLRX
$1.15
$0.021.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.37M | -20.04M | -23.58M | -26.30M | -43.30M |
| Total Depreciation and Amortization | 249.00K | 264.00K | 365.00K | 436.00K | 447.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.91M | 5.41M | 7.46M | 7.53M | 9.17M |
| Change in Net Operating Assets | 4.41M | -4.87M | -2.04M | -2.75M | -6.92M |
| Cash from Operations | -12.80M | -19.23M | -17.79M | -21.08M | -40.60M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -112.00K |
| Sale of Property, Plant, and Equipment | 17.00K | 102.00K | -1.00K | 156.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.47M | -4.20M | 1.77M | 27.77M | 35.60M |
| Cash from Investing | 15.49M | -4.10M | 1.77M | 27.92M | 35.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -32.27M | -- | -- |
| Issuance of Common Stock | 0.00 | 74.00K | 0.00 | 72.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 74.00K | -32.27M | 72.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.69M | -23.26M | -48.29M | 6.91M | -5.12M |